Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
Recruiting · NCT07516093 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL | B-cell chronic lymphocytic leukemia, B-cell neoplasm, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2026-08-31 | NCT07516093 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nurix Therapeutics, Inc. | 6 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Central Georgia Cancer Care | Macon | United States | 5 |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne | United States | 22 |
| Hematology Oncology of Indiana | Indianapolis | United States | 6 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Texas Oncology - West Texas | Midland | United States | 1 |
| Virginia Cancer Specialists | Fairfax | United States | 1 |